We are live on
!
Find out more
Man Group Portfolio holdings
AUM
$55.1B
1-Year Est. Return
24.23%
This Fund
S&P 500
This Quarter
Est. Return
+12.77%
1 Year Est. Return
+24.23%
3 Year Est. Return
+82.67%
5 Year Est. Return
+105.49%
10 Year Est. Return
–
AUM
$52.5B
AUM Growth
+$13.1B
(+33%)
Cap. Flow
+$7.72B
Cap. Flow
% of AUM
14.72%
Top 10 Holdings %
Top 10 Hldgs %
17.31%
Holding
2,462
New
319
Increased
921
Reduced
776
Closed
312
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.09B |
| 2 |
NVIDIA
NVDA
|
+$436M |
| 3 |
Apple
AAPL
|
+$415M |
| 4 |
Microsoft
MSFT
|
+$396M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$270M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booz Allen Hamilton
BAH
|
+$120M |
| 2 |
Walt Disney
DIS
|
+$115M |
| 3 |
Wingstop
WING
|
+$89.6M |
| 4 |
Cisco
CSCO
|
+$88.1M |
| 5 |
Amphenol
APH
|
+$84.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.78% |
| 2 | Healthcare | 10.33% |
| 3 | Financials | 10.22% |
| 4 | Consumer Discretionary | 10.18% |
| 5 | Industrials | 7.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VMEO
1976
DELISTED
Vimeo
VMEO
| $169K | ﹤0.01% |
41,849
-76,737
| -65% | -$355K |
|
|
TDAY
1977
USA Today Co
TDAY
$1.23B
| $169K | ﹤0.01% |
47,071
-27,895
| -37% | -$93.5K |
|
1978
Cullinan Oncology
CGEM
$1.05B
| $168K | ﹤0.01% |
+22,341
| New | +$180K |
|
1979
Ironwood Pharmaceuticals
IRWD
$611M
| $168K | ﹤0.01% |
234,257
-99,461
| -30% | -$78.1K |
|
|
UNIT
1980
Uniti Group
UNIT
$2.63B
| $168K | ﹤0.01% |
38,825
-42,482
| -52% | -$191K |
|
1981
Monte Rosa Therapeutics
GLUE
$1.92B
| $164K | ﹤0.01% |
+36,391
| New | +$162K |
|
1982
Spyre Therapeutics
SYRE
$8.87B
| $162K | ﹤0.01% |
+10,843
| New | +$160K |
|
1983
Playtika
PLTK
$1.4B
| $162K | ﹤0.01% |
34,302
+21,377
| +165% | +$105K |
|
1984
Bumble
BMBL
$367M
| $156K | ﹤0.01% |
23,723
-118,661
| -83% | -$599K |
|
1985
Granite Ridge Resources
GRNT
$640M
| $156K | ﹤0.01% |
24,505
-3,328
| -12% | -$18.3K |
|
1986
Akebia Therapeutics
AKBA
$327M
| $152K | ﹤0.01% |
+41,711
| New | +$115K |
|
|
ITRG
1987
Integra Resources
ITRG
$438M
| $149K | ﹤0.01% |
+99,127
| New | +$159K |
|
1988
United Microelectronic
UMC
$48.9B
| $148K | ﹤0.01% |
19,346
-180,703
| -90% | -$1.34M |
|
1989
Concrete Pumping Holdings
BBCP
$531M
| $147K | ﹤0.01% |
23,962
-6,723
| -22% | -$42.6K |
|
1990
Anika Therapeutics
ANIK
$199M
| $140K | ﹤0.01% |
+13,268
| New | +$167K |
|
1991
Janus International
JBI
$722M
| $140K | ﹤0.01% |
17,183
-954
| -5% | -$7.27K |
|
1992
B2Gold
BTG
$5.16B
| $135K | ﹤0.01% |
37,469
-319,709
| -90% | -$1.05M |
|
1993
Marqeta
MQ
$1.8B
| $134K | ﹤0.01% |
5,763
+1,597
| +38% | +$30.3K |
|
1994
Heritage Global
HGBL
$41.7M
| $133K | ﹤0.01% |
59,874
-13,623
| -19% | -$28.5K |
|
1995
dLocal
DLO
$4.26B
| $130K | ﹤0.01% |
+11,472
| New | +$113K |
|
1996
Clover Health Investments
CLOV
$2.28B
| $121K | ﹤0.01% |
43,475
+14,602
| +51% | +$48K |
|
1997
Arbutus Biopharma
ABUS
$865M
| $121K | ﹤0.01% |
+38,997
| New | +$129K |
|
|
DENN
1998
DELISTED
Denny's
DENN
| $120K | ﹤0.01% |
+29,298
| New | +$112K |
|
1999
Ring Energy
REI
$322M
| $115K | ﹤0.01% |
144,231
-26,208
| -15% | -$22.2K |
|
2000
Entrada Therapeutics
TRDA
$227M
| $113K | ﹤0.01% |
+16,805
| New | +$135K |
|
Similar funds
Man Group's Q2 2025 Portfolio in Review
As of Q2 2025, Man Group held 2,462 positions worth $52.5B, up 33% from $39.4B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Man Group deployed $7.72B of net new capital in Q2 2025, opening 319 new positions and adding to 921 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 1,900,024 shares worth $1.17B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Booz Allen Hamilton, an estimated $120M trimmed.
- Man Group's largest Q2 2025 buy was State Street SPDR S&P 500 ETF Trust: 1,900,024 shares worth $1.17B.
- Man Group added most to NVIDIA in Q2 2025, an estimated $436M increase.
- Man Group's biggest Q2 2025 reduction was Booz Allen Hamilton, cutting an estimated $120M.
- Man Group fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $81.9M.
- Man Group's ten largest holdings make up 17% of its $52.5B portfolio in Q2 2025.
- Man Group opened 319 new positions and closed 312 in Q2 2025.
- Man Group's portfolio value rose 33% quarter-over-quarter to $52.5B.
Based on Man Group's 13F filing for Q2 2025, filed 14 Aug 2025.